Antharis Therapeutics is a multinational biopharmaceutical company developing new treatments for cancer, inflammatory and infectious diseases. In particular, our company utilizes cutting-edge science to develop therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs.
The company, founded by Dr. Raphael R Pinaud in 2020, has significantly grown and successfully advanced its mission to date. Furthermore, Antharis strategically acquired Cassyni Biopharma and Galileo Biotech, in mid-2022 and mid-2023, respectively, to further and more effectively advance its mandate to bring transformational therapies to patients in need.
-
Industry
-
Biotechnology
-
Company size
-
11-50 employees
-
Headquarters
-
San Diego, CA
-
Type
-
Privately Held
-
Founded
-
2020
-
Specialties
-
antibodies, therapies, antibody drug conjugates, therapeutic antibodies, monoclonal antibodies, neurology, neuroscience, neurological disorders, alzheimer's disease, parkinson's disease, multiple sclerosis, cancer, oncology, cancer biology, biotechnology, biotech, pharmaceutical, and biopharma